Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of SAR292833 in Chronic Peripheral Neuropathic Pain
NCT01463397Phase 2Completed
- Sponsor
- Sanofi
- Start
- Mar 2012
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of GRC-15300 in diabetic polyneuropathy (DPN), postherpetic neuralgia (PHN), sponsored by Sanofi. Started Mar 2012; status: completed.
02
Drugs
GRC-15300
03
Conditions
diabetic polyneuropathy (DPN)postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT01463397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01463397.